Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

被引:55
作者
Koh, Ye Xin [1 ]
Tan, Hiang Jin [1 ]
Liew, Yi Xin [2 ]
Syn, Nicholas [1 ]
Teo, Jin Yao [1 ,4 ]
Lee, Ser Yee [1 ,4 ]
Goh, Brian K. P. [1 ,4 ]
Goh, George B. B. [3 ,4 ]
Chan, Chung Yip [1 ,4 ]
机构
[1] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplant Surg, 20 Coll Rd, Singapore 169856, Singapore
[2] Singapore Gen Hosp, Dept Pharm, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[4] Duke Natl Univ Singapore, Singapore, Singapore
关键词
NAFLD; STEATOHEPATITIS; SURVIVAL;
D O I
10.1016/j.jamcollsurg.2019.07.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) is on the rise worldwide, but data on long-term outcomes after curative operations are limited. The primary aim of this study was to characterize the perioperative and long-term outcomes after liver resection. The secondary aim was to investigate the influence of the histologic severity of nonalcoholic steatohepatitis and its impact on perioperative outcomes and long-term survival. METHODS: A total of 996 patients who underwent liver resection for HCC in our institution were analyzed. Patients were categorized into subgroups of NAFLD vs non-NAFLD HCC based on histologic evidence of hepatic steatosis. Comparisons of patients' demographic, clinical, and surgical characteristics; postoperative complications; and survival outcomes were performed. RESULTS: Eight hundred and forty-four patients had non-NAFLD HCC and 152 patients had NAFLD HCC. Comorbidities were significantly more common in the NAFLD group (p < 0.0001). In the non-NAFLD group, larger median tumor size, higher liver cirrhosis, and lower median neutrophil to lymphocyte ratio were observed (p < 0.0001). The NAFLD group had a greater amount of intraoperative blood loss, more postoperative complications, and longer length of stay. Five-year overall survival was significantly better in the NAFLD group (p = 0.0355). Significant factors that contribute to poorer survival outcomes include age, congestive cardiac failure, Child-Pugh's class B, cirrhosis, tumor size, multinodularity, and R1 resection. For NAFLD group, patients with abnormal parenchyma showed poorer survival and 5-year overall survival rates (64.8% vs 75.6%; p = 0.2291). CONCLUSIONS: Nonalcoholic fatty liver disease-related HCC is associated with greater surgical morbidity and post-hepatectomy liver failure. Despite this, long-term survival outcomes are favorable compared with non-NAFLD etiologies. ((C) 2019 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)
引用
收藏
页码:467 / +
页数:13
相关论文
共 50 条
  • [21] The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
    Kogiso, Tomomi
    Tokushige, Katsutoshi
    CANCERS, 2021, 13 (03) : 1 - 17
  • [22] From Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: A Systems Understanding
    Rozman, Damjana
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (02) : 238 - 241
  • [23] Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Azuma, Seishin
    Asahina, Yasuhiro
    Kakinuma, Sei
    Azuma, Keiko
    Miyoshi, Masato
    Inoue, Emi
    Tsunoda, Tomoyuki
    Sato, Ayako
    Kaneko, Shun
    Nagata, Hiroko
    Kawai-Kitahata, Fukiko
    Murakawa, Miyako
    Nitta, Sayuri
    Itsui, Yasuhiro
    Tomita, Makoto
    Nakagawa, Mina
    Watanabe, Mamoru
    DIGESTIVE DISEASES, 2019, 37 (03) : 247 - 254
  • [24] Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey
    Katsutoshi Tokushige
    Hideyuki Hyogo
    Tomoaki Nakajima
    Masafumi Ono
    Takumi Kawaguchi
    Koichi Honda
    Yuichiro Eguchi
    Yuichi Nozaki
    Miwa Kawanaka
    Saiyu Tanaka
    Kento Imajo
    Yoshio Sumida
    Yoshihiro Kamada
    Hideki Fujii
    Yasuaki Suzuki
    Tomomi Kogiso
    Yoshiyasu Karino
    Kensuke Munekage
    Ryoko Kuromatsu
    Satoshi Oeda
    Mikio Yanase
    Kohjiro Mori
    Yuji Ogawa
    Yuya Seko
    Tetsuo Takehara
    Yoshito Itoh
    Atsushi Nakajima
    Kazuyuki Kanemasa
    Ken Nishino
    Naohiko Masaki
    Hirokazu Takahashi
    Masataka Seike
    Takuji Torimura
    Toshiji Saibara
    Joji Toyota
    Kazuaki Chayama
    Etsuko Hashimoto
    Journal of Gastroenterology, 2016, 51 : 586 - 596
  • [25] Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement
    Cerrito, Lucia
    Mignini, Irene
    Ainora, Maria Elena
    Mosoni, Carolina
    Gasbarrini, Antonio
    Zocco, Maria Assunta
    CANCERS, 2023, 15 (03)
  • [26] Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
    Behari, Jaideep
    Gougol, Amir
    Wang, Renwei
    Luu, Hung N.
    Paragomi, Pedram
    Yu, Yi-Chuan
    Molinari, Michele
    Chopra, Kapil
    Malik, Shahid M.
    Geller, David
    Yuan, Jian-Min
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (07)
  • [27] Nonalcoholic Fatty Liver Disease After Liver Transplantation for Cryptogenic Cirrhosis or Nonalcoholic Fatty Liver Disease
    Yalamanchili, Kanthi
    Saadeh, Sherif
    Klintmalm, Goeran B.
    Jennings, Linda W.
    Davis, Gary L.
    LIVER TRANSPLANTATION, 2010, 16 (04) : 431 - 439
  • [28] Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma
    Liu, Baiyi
    Wang, Xiaoxiao
    Wu, Nan
    Liu, Feng
    Rao, Huiying
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [29] Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Pelusi, Serena
    Baselli, Guido
    Pietrelli, Alessandro
    Dongiovanni, Paola
    Donati, Benedetta
    McCain, Misti Vanette
    Meroni, Marica
    Fracanzani, Anna Ludovica
    Romagnoli, Renato
    Petta, Salvatore
    Grieco, Antonio
    Miele, Luca
    Soardo, Giorgio
    Bugianesi, Elisabetta
    Fargion, Silvia
    Aghemo, Alessio
    D'Ambrosio, Roberta
    Xing, Chao
    Romeo, Stefano
    De Francesco, Raffaele
    Reeves, Helen Louise
    Valenti, Luca Vittorio Carlo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
    Alqahtani, Saleh A.
    Chan, Wah-Kheong
    Yu, Ming-Lung
    CLINICS IN LIVER DISEASE, 2023, 27 (02) : 211 - 223